Category Archives: U.S. Policy and Funding

AIDS docs debate how and when to scale up treatment as prevention

By on .

In the sixth in a series of debates about the world’s HIV response hosted by the World Bank and USAID, physician-scientists debated how best to transform the exciting results from the HPTN) 052 study, which demonstrated that those with HIV infection who received immediate treatment with antiretroviral therapy (ART) were 96 percent less likely to transmit HIV to their uninfected sexual partners than those whose treatment was delayed. The panelists were tasked with debating not only how to apply treatment as prevention (TasP) quickly, and how to add it to the combination prevention tool kit effectively, but more so whether or not it makes sense to have countries spend a majority of what is likely to be a flat or declining HIV prevention budget on TasP.